Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012, Article ID 372474, 8 pages
http://dx.doi.org/10.1100/2012/372474
Clinical Study

The Efficacy of Pramipexole, a Dopamine Receptor Agonist, as an Adjunctive Treatment in Treatment-Resistant Depression: An Open-Label Trial

Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan

Received 27 March 2012; Accepted 29 April 2012

Academic Editors: J. H. Beitchman and Y. Bloch

Copyright © 2012 Hiroaki Hori and Hiroshi Kunugi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [20 citations]

The following is the list of published articles that have cited the current article.

  • D. Gourion, and P. M. Llorca, “Anhedonia in depression,” Encephale-Revue de Psychiatrie Clinique Biologique et Therapeutique, vol. 39, no. 4, pp. 296–305, 2013. View at PublisherView at Google Scholar
  • Hiroaki Hori, “Dopamine agonist-responsive depression,” Psychogeriatrics, vol. 13, no. 3, pp. 189–195, 2013. View at PublisherView at Google Scholar
  • Domenico De Berardis, Stefano Marini, Nicola Serroni, Gabriella Rapini, Felice Iasevoli, Alessandro Valchera, Maria Signorelli, Eugenio Aguglia, Giampaolo Perna, Anatolia Salone, Giuseppe Di Iorio, Giovanni Martinotti, and Massimo Di Giannantonio, “S-Adenosyl-L-Methionine Augmentation in Patients with Stage II Treatment-Resistant Major Depressive Disorder: An Open Label, Fixed Dose, Single-Blind Study,” The Scientific World Journal, vol. 2013, pp. 1–5, 2013. View at PublisherView at Google Scholar
  • Elizabeth K. Nousen, Juliana G. Franco, and Elinor L. Sullivan, “Unraveling the Mechanisms Responsible for the Comorbidity between Metabolic Syndrome and Mental Health Disorders,” Neuroendocrinology, vol. 98, no. 4, pp. 254–266, 2013. View at PublisherView at Google Scholar
  • Pierre Blier, “Rational site-directed pharmacotherapy for major depressive disorder,” International Journal of Neuropsychopharmacology, vol. 17, no. 7, pp. 997–1008, 2014. View at PublisherView at Google Scholar
  • Kristin M. Pearson-Fuhrhop, Erin C. Dunn, Sarah Mortero, William J. Devan, Guido J. Falcone, Phil Lee, Avram J. Holmes, Marisa O. Hollinshead, Joshua L. Roffman, Jordan W. Smoller, Jonathan Rosand, and Steven C. Cramer, “Dopamine Genetic Risk Score Predicts Depressive Symptoms in Healthy Adults and Adults with Depression,” Plos One, vol. 9, no. 5, 2014. View at PublisherView at Google Scholar
  • Vivian Binder Neis, Morgana Moretti, Luana Meller Manosso, Mark W. Lopes, Rodrigo Bainy Leal, and Ana Lúcia S. Rodrigues, “Agmatine enhances antidepressant potency of MK-801 and conventional antidepressants in mice,” Pharmacology Biochemistry and Behavior, 2014. View at PublisherView at Google Scholar
  • Irvin Epstein, Isaac Szpindel, and Martin A. Katzman, “Pharmacological approaches to manage persistent symptoms of major depressive disorder: rationale and therapeutic strategies,” Psychiatry Research, vol. 220, pp. S15–S33, 2014. View at PublisherView at Google Scholar
  • Bart P. de Kwaasteniet, Chedwa Pinto, Eric H. G. Ruhe, Guido A. van Wingen, Jan Booij, and Damiaan Denys, “Striatal Dopamine D-2/3 Receptor Availability in Treatment Resistant Depression,” Plos One, vol. 9, no. 11, 2014. View at PublisherView at Google Scholar
  • Andre F. Carvalho, Michael Berk, Thomas N. Hyphantis, and Roger S. McIntyre, “The Integrative Management of Treatment-Resistant Depression: A Comprehensive Review and Perspectives,” Psychotherapy and Psychosomatics, vol. 83, no. 2, pp. 70–88, 2014. View at PublisherView at Google Scholar
  • Hiroaki Oguro, Katsuhiko Kadota, Masaki Ishihara, Kazunori Okada, and Shuhei Yamaguchi, “Efficacy of Pramipexole for Treatment of Apathy in Parkinson’s Disease,” International Journal of Clinical Medicine, vol. 05, no. 15, pp. 885–889, 2014. View at PublisherView at Google Scholar
  • Antonio Tundo, Rocco de Filippis, and Luca Proietti, “Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.,” World journal of psychiatry, vol. 5, no. 3, pp. 330–41, 2015. View at PublisherView at Google Scholar
  • Joji Maruo, Yoshinori Haraguchi, Hiroshi Tateishi, Tomoyuki Noguchi, Yoshito Mizoguchi, Takahiro A. Kato, Toshiro Kawashima, and Akira Monji, “Abnormal behaviours during pramipexole treatment for Cotard's syndrome: a case report,” Psychogeriatrics, 2015. View at PublisherView at Google Scholar
  • Hiroshi Kunugi, Hiroaki Hori, and Shintaro Ogawa, “Biochemical markers subtyping major depressive disorder,” Psychiatry and Clinical Neurosciences, 2015. View at PublisherView at Google Scholar
  • Shintaro Ogawa, and Hiroshi Kunugi, “Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants,” Current Neuropharmacology, vol. 13, no. 6, pp. 760–775, 2015. View at PublisherView at Google Scholar
  • Xue Qing Yang, Daniel Glizer, Andrew Vo, Ken N. Seergobin, and Penny A. MacDonald, “Pramipexole Increases Go Timeouts but Not No-go Errors in Healthy Volunteers,” Frontiers in Human Neuroscience, vol. 10, 2016. View at PublisherView at Google Scholar
  • Hyung Shin Yoon, Kotaro Hattori, Daimei Sasayama, Toshiya Teraishi, Shintaro Ogawa, Miho Ota, and Hiroshi Kunugi, “Relationships of cerebrospinal fluid monoamine metabolite levels with clinical variables in major depressive disorder,” Journal of Clinical Psychiatry, vol. 78, no. 8, pp. e947–e956, 2017. View at PublisherView at Google Scholar
  • Mi-Hyun Choi, Ji Eun Na, Ye Ran Yoon, Hyo Jin Lee, Sehyoun Yoon, Im Joo Rhyu, and Ja-Hyun Baik, “Role of Dopamine D2 Receptor in Stress-Induced Myelin Loss,” Scientific Reports, vol. 7, no. 1, 2017. View at PublisherView at Google Scholar
  • Claire Gauthier, Lama Souaiby, Emmanuelle Advenier-Iakovlev, and Raphaël Gaillard, “Pramipexole and Electroconvulsive Therapy in Treatment-Resistant Depression,” Clinical Neuropharmacology, vol. 40, no. 6, pp. 264–267, 2017. View at PublisherView at Google Scholar
  • Shintaro Ogawa, Shoko Tsuchimine, and Hiroshi Kunugi, “Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence,” Journal of Psychiatric Research, 2018. View at PublisherView at Google Scholar